JP Morgan Chase & Co’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $508K | Buy |
|
|||||
|
2025
Q2 | $382K | Sell |
|
|||||
|
2025
Q1 | $428K | Buy |
|
|||||
|
2024
Q4 | $444K | Sell |
|
|||||
|
2024
Q3 | $531K | Buy |
|
|||||
|
2024
Q2 | $486K | Buy |
|
|||||
|
2024
Q1 | $323K | Sell |
|
|||||
|
2023
Q4 | $332K | Sell |
|
|||||
|
2023
Q3 | $362K | Sell |
|
|||||
|
2023
Q2 | $626K | Buy |
|
|||||
|
2023
Q1 | $2K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $0 | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $33K | Sell |
|
|||||
|
2021
Q2 | $80K | Sell |
|
|||||
|
2021
Q1 | $177K | Buy |
|
|||||
|
2020
Q4 | $453K | Buy |
|
|||||
|
2020
Q3 | $68K | Sell |
|
|||||
|
2020
Q2 | $117K | Buy |
|